YPS3 Antibody

What is YPS3 antibody and what is its immunological classification?

YPS3 is one of three murine monoclonal antibodies (alongside Yps1 and Yps2) that are reactive to Yersinia pseudotuberculosis. YPS3 belongs to the IgG class of immunoglobulins, making it suitable for a wide range of immunological applications. This antibody has been developed specifically to recognize protein antigens of Y. pseudotuberculosis and demonstrates high specificity in research and diagnostic applications .

What molecular weight antigens does YPS3 recognize and how does this compare to other Yersinia-reactive antibodies?

YPS3 specifically recognizes protein antigens of Y. pseudotuberculosis in the 26-28 kDa molecular weight range. This recognition profile differs significantly from other Yersinia-reactive antibodies. For comparison, Yps1 recognizes a glycoprotein antigen with reactivity in the 55-75 kDa range, while Yps2 targets protein antigens around 65 kDa. These distinct recognition profiles allow researchers to target specific antigens depending on their experimental needs .

What is the specificity profile of YPS3 across different bacterial species?

The reactivity of YPS3 monoclonal antibody is predominantly restricted to Y. pseudotuberculosis and Y. pestis when tested with soluble antigen preparations. Specificity testing conducted with dot ELISA and Western blotting against whole cell organisms or sonicated soluble antigens from various bacterial species (including different Yersinia species, Salmonella typhi, Klebsiella pneumoniae, Streptococcus abortus-equi, and Escherichia coli) confirmed this limited cross-reactivity profile. Notably, while YPS3 reacts with soluble antigen preparations from Y. pseudotuberculosis and Y. pestis, it does not react with whole cell organism preparations from these or other tested bacteria .

How stable is YPS3 antibody and what are optimal storage conditions?

While the search results don't specifically address YPS3 stability, general antibody storage guidelines (similar to those mentioned for YPEL3 antibody) can be applied. Monoclonal antibodies like YPS3 can typically be stored at 4°C for short-term use (approximately three months) and at -20°C for long-term storage (up to one year). To maintain activity, it's crucial to avoid repeated freeze-thaw cycles, as these can lead to antibody degradation. Additionally, antibodies should not be exposed to prolonged high temperatures .

What immunoassay formats have been validated for YPS3 antibody?

YPS3 has been successfully employed in multiple immunoassay formats, with particularly strong performance in:

• Dot ELISA: YPS3 shows specific reactivity to Y. pseudotuberculosis and Y. pestis in dot ELISA formats when using soluble antigen preparations.

• Western Blotting: The antibody has been validated for Western blotting applications with soluble antigen preparations.

• Sandwich dot ELISA: YPS3 demonstrates a high level of specificity when used as a revealing antibody in sandwich dot ELISA, with monospecific antisera serving as the capture antibody. This combination creates a powerful detection system specifically for Y. pseudotuberculosis antigens .

How can YPS3 be incorporated into co-agglutination assays for bacterial detection?

While YPS3 itself was not specifically used in co-agglutination assays according to the search results, the related antibody Yps1 was successfully employed in such applications. Following a similar methodology:

• Prepare staphylococcal cells according to standard protocols

• Sensitize the prepared cells with purified YPS3 monoclonal antibody

• Test the sensitized cells against bacterial suspensions

• Observe for visible agglutination reactions

Based on results with Yps1, which produced positive agglutination with all 4 Y. pseudotuberculosis isolates and 3 Y. pestis strains tested, YPS3 might theoretically show similar utility but with greater specificity for the 26-28 kDa protein antigens it recognizes .

What is the optimal sandwich ELISA configuration using YPS3 for maximum sensitivity?

The most effective sandwich ELISA configuration using YPS3 involves:

• Coating wells with monospecific antisera as the capture antibody

• Adding the test sample containing potential Y. pseudotuberculosis antigens

• Using YPS3 as the revealing (detection) antibody

• Completing the detection system with an appropriate secondary antibody or direct label

This configuration has demonstrated a high level of specificity in detecting Y. pseudotuberculosis antigens, making it particularly valuable for applications requiring selective detection of this pathogen in complex samples .

How does YPS3 cross-reactivity compare to Yps1 and Yps2 antibodies?

The three monoclonal antibodies show distinct cross-reactivity profiles:

YPS3 demonstrates the highest specificity among the three antibodies, making it particularly valuable for selective detection of Y. pseudotuberculosis and Y. pestis in the presence of other bacterial species .

What strategies can minimize potential cross-reactivity when using YPS3 in complex samples?

To minimize cross-reactivity when using YPS3 in complex biological or environmental samples:

• Implement a sandwich assay format with a complementary capture antibody to increase specificity

• Use appropriate blocking agents to reduce non-specific binding

• Optimize sample preparation methods to isolate the target antigen

• Consider using flow-through immunoassay systems, which have been shown to minimize matrix interference and antibody cross-reactivity challenges in other immunoassay contexts

• Include appropriate controls to identify potential cross-reactivity issues

• Test with known cross-reactive antigens to establish assay limitations

These approaches can dramatically improve assay specificity in the presence of potentially cross-reactive compounds or organisms .

How can researchers validate the specificity of YPS3 in their experimental systems?

A comprehensive validation strategy for YPS3 specificity should include:

• Testing against a panel of related and unrelated bacterial species

• Evaluating performance with both pure cultures and mixed populations

• Testing with various sample matrices relevant to the intended application

• Performing blocking experiments to confirm specificity

• Comparing results with alternative detection methods (e.g., PCR, culture)

• Using appropriate positive and negative controls

• Quantifying the limit of detection and limit of quantification in the specific experimental system

This systematic approach ensures that YPS3-based assays provide reliable and specific detection of Y. pseudotuberculosis in the researcher's particular experimental context .

What are common sources of false positives and negatives when using YPS3 antibody?

Common sources of false results when using YPS3 antibody include:

False Positives:

• Cross-reactivity with Y. pestis (this is an expected cross-reaction based on antibody characterization)

• Insufficient blocking leading to non-specific binding

• Sample matrix interference effects

• Secondary antibody cross-reactivity

• Contamination during assay preparation

False Negatives:

• Target antigen denaturation during sample preparation

• Insufficient antigen concentration (below detection limit)

• Interfering substances in the sample matrix

• Antibody deterioration due to improper storage

• Suboptimal assay conditions (buffer composition, pH, temperature)

To address these issues, researchers should implement appropriate controls, optimize assay conditions, and consider using alternative formats such as sandwich ELISA to improve specificity and sensitivity .

How can YPS3-based assays be optimized for enhanced sensitivity?

To enhance the sensitivity of YPS3-based assays:

• Consider signal amplification strategies such as:

  • Enzyme-mediated amplification systems

  • Biotin-streptavidin detection systems

  • Tyramide signal amplification

• Optimize antibody concentrations through titration experiments

• Evaluate alternative detection systems (chemiluminescence vs. colorimetric)

• Implement sample pre-concentration techniques for dilute samples

• Use miniaturized flow-through immunoassay systems, which have been shown to enhance sensitivity by maintaining optimal reaction kinetics

• Optimize buffer compositions to improve antibody-antigen binding while minimizing background

• Consider temperature and incubation time optimization

These strategies can significantly improve the lower limit of detection for Y. pseudotuberculosis using YPS3-based assays .

What buffer systems are optimal for YPS3 antibody performance?

While specific buffer optimization data for YPS3 is not available in the search results, general principles for monoclonal antibody performance suggest:

• For coating and capture: Carbonate-bicarbonate buffer (pH 9.6) or phosphate-buffered saline (PBS, pH 7.4)

• For antibody dilution: PBS containing 0.05-0.1% Tween-20 and 1-5% blocking protein (BSA or casein)

• For washing: PBS with 0.05-0.1% Tween-20

• For blocking: PBS with 1-5% BSA, casein, or non-fat dry milk

• For sample dilution: PBS containing 0.05-0.1% Tween-20 and 0.5-1% blocking protein

Buffer optimization should be performed empirically for each specific application to achieve optimal signal-to-noise ratios and assay performance .

How can YPS3 antibody be utilized in multiplexed detection systems?

YPS3 can be incorporated into multiplexed detection systems for simultaneous detection of multiple pathogens or antigens:

• Multiplex bead-based immunoassays:

  • Conjugate YPS3 to distinctly colored/coded microbeads

  • Combine with other antibody-conjugated beads targeting different pathogens

  • Analyze using flow cytometry or specialized plate readers

• Protein microarrays:

  • Spot YPS3 alongside other capture antibodies on functionalized surfaces

  • Process samples across the entire array

  • Detect binding events using labeled secondary antibodies or direct labeling approaches

• Multiplex ELISA formats:

  • Use spatial separation in multi-well formats

  • Implement with different detection systems (enzymes producing distinct colors)

These approaches enable simultaneous screening for Y. pseudotuberculosis alongside other pathogens, enhancing diagnostic efficiency and throughput .

What are potential research applications for YPS3 beyond basic detection of Y. pseudotuberculosis?

YPS3 antibody has potential applications beyond basic pathogen detection:

• Pathogenesis studies:

  • Tracking antigen expression during different growth phases

  • Localizing target antigens through immunofluorescence microscopy

  • Monitoring antigen secretion in infection models

• Immunotherapy research:

  • Exploring antibody-based therapies against Yersinia infections

  • Studying antibody neutralization mechanisms

• Structural biology:

  • Epitope mapping of the 26-28 kDa target protein

  • Analyzing conformational changes in target antigens under different conditions

• Vaccine development:

  • Screening candidate vaccines for appropriate antigen expression

  • Evaluating immune responses to vaccination

• Environmental monitoring:

  • Developing field-deployable detection systems

  • Creating biosensors for continuous monitoring

These diverse applications highlight the versatility of YPS3 as a research tool beyond its primary diagnostic use .

How does the CDR3 region influence YPS3 binding specificity and what implications does this have for antibody engineering?

While the specific CDR3 characteristics of YPS3 are not detailed in the search results, research on antibody binding mechanisms provides insights into how CDR3 regions influence specificity:

The complementarity-determining region 3 (CDR3) plays a crucial role in antibody specificity. Research on other antibodies has shown that features such as CDR3 length, amino acid composition (particularly the presence of tyrosine residues), and polar amino acid content significantly influence binding properties. For instance, in dengue virus antibodies, the presence of tyrosine-rich motifs in heavy chain CDR3 has been associated with broad neutralization capacity .

For antibody engineering applications involving YPS3:

• Characterizing the CDR3 sequence of YPS3 could provide insights into its specificity for the 26-28 kDa Y. pseudotuberculosis antigens

• Modifications to the CDR3 region through directed evolution or rational design could potentially:

  • Enhance binding affinity

  • Modify cross-reactivity profiles

  • Improve thermal stability

  • Alter recognition of specific epitopes

• Understanding the relationship between CDR3 sequence and specificity could inform the development of next-generation diagnostic antibodies with enhanced performance characteristics

This advanced understanding of antibody structure-function relationships represents a frontier in antibody engineering research .

How does YPS3-based detection compare with nucleic acid amplification techniques for Y. pseudotuberculosis?

Both methods have complementary strengths, with antibody-based detection offering rapid results with minimal equipment, while nucleic acid methods provide superior sensitivity and specificity. In many research and diagnostic settings, a combination of both approaches may provide the most comprehensive analysis .

What are the advantages of using YPS3 in a sandwich ELISA compared to other immunoassay formats?

Sandwich ELISA using YPS3 offers several advantages over other immunoassay formats:

• Enhanced specificity: The use of two antibodies (capture and detection) creates a more stringent detection system, reducing false positives

• Improved sensitivity: The dual antibody approach amplifies detection signals while maintaining low background

• Greater sample compatibility: Effective with complex sample matrices without extensive purification

• Reduced matrix effects: The wash steps between antibody applications minimize interference from sample components

• Quantitative capability: Provides reliable quantification of target antigens when used with appropriate standards

• Flexibility: Can be adapted to various detection systems (colorimetric, fluorescent, chemiluminescent)

• Scalability: Easily automated for high-throughput applications

The sandwich format is particularly valuable for YPS3 applications given its already high specificity, further enhancing its utility for selective detection of Y. pseudotuberculosis antigens .

How can machine learning be integrated with YPS3-based detection for improved diagnostic accuracy?

Machine learning approaches can significantly enhance YPS3-based detection systems:

• Signal interpretation optimization:

  • Algorithms can help distinguish true positive signals from background noise

  • Pattern recognition can identify characteristic binding profiles

  • Automated threshold determination improves consistency

• Multiparameter analysis:

  • Incorporation of multiple data points (signal intensity, binding kinetics, etc.)

  • Integration with other biomarkers for comprehensive analysis

  • Classification of samples based on complex feature sets

• Predictive modeling:

  • Forecasting disease progression based on antigen levels

  • Risk stratification based on detection patterns

  • Epidemic modeling incorporating detection data

• Continuous improvement:

  • Learning algorithms that adapt to new data

  • Refinement of detection parameters over time

  • Identification of previously unrecognized patterns

Similar approaches have been successfully applied to dengue antibody response analysis, where machine learning helped identify rare broadly neutralizing antibodies by analyzing complex repertoire data. These techniques could be adapted to YPS3-based systems to enhance sensitivity, specificity, and interpretative power .

How might structural antibody databases inform future development of improved YPS3-like antibodies?

Structural antibody databases like the Therapeutic Structural Antibody Database (Thera-SAbDab) offer significant potential for enhancing YPS3-like antibodies:

• Structure-guided optimization:

  • Analysis of complementarity-determining regions (CDRs) that contribute to specificity

  • Identification of framework modifications to improve stability

  • Structure-based predictions of binding affinity

• Comparative analysis:

  • Benchmarking YPS3 against structurally characterized antibodies with similar targets

  • Identifying structural features associated with high specificity

  • Learning from naturally occurring antibody structures

• In silico modeling:

  • Predicting interactions between YPS3 and its target epitope

  • Virtual screening of antibody variants

  • Computational design of enhanced versions

• Epitope mapping:

  • Understanding structural basis of cross-reactivity with Y. pestis

  • Identifying conserved epitopes for broad detection

  • Pinpointing unique structural features for differential diagnosis

These databases, which track antibody and nanobody therapeutics and identify corresponding structures, provide valuable resources for rational antibody engineering that could lead to next-generation Yersinia-specific diagnostic antibodies .

Can YPS3 antibody be adapted for point-of-care or field-deployable diagnostic devices?

YPS3 antibody shows promising characteristics for adaptation to point-of-care (POC) and field-deployable formats:

• Lateral flow immunoassays (LFIA):

  • YPS3 could be gold-conjugated for visible detection lines

  • Paired with appropriate capture antibodies for sandwich formats

  • Integrated with sample preparation for complex matrices

• Microfluidic systems:

  • YPS3 incorporated into miniaturized flow-through systems

  • Integration with automated sample processing

  • Potential for multiplexed detection with other pathogen-specific antibodies

• Smartphone-based detection:

  • LFIA readers using smartphone cameras

  • Image analysis algorithms for quantitative results

  • Cloud connectivity for data sharing and analysis

• Biosensor applications:

  • Immobilization on electrochemical sensors

  • Integration with optical detection systems

  • Continuous monitoring applications

The high specificity of YPS3 for Y. pseudotuberculosis and Y. pestis makes it particularly valuable for field settings where rapid, specific detection is critical for public health response. The deployment of such systems could significantly enhance surveillance capabilities, especially in resource-limited settings .

What experimental approaches would help characterize the epitope recognized by YPS3 antibody?

To characterize the specific epitope recognized by YPS3 antibody:

• Proteolytic fragmentation analysis:

  • Generate peptide fragments of the 26-28 kDa target protein

  • Test fragment reactivity with YPS3

  • Sequence reactive fragments to identify the epitope region

• Recombinant protein expression:

  • Create truncated versions of the target protein

  • Express point mutations within the suspected epitope region

  • Evaluate binding to identify critical residues

• Phage display techniques:

  • Screen peptide libraries for YPS3 binding

  • Identify consensus sequences that mimic the natural epitope

  • Confirm findings with competitive binding assays

• X-ray crystallography or cryo-EM:

  • Determine the structure of YPS3 Fab in complex with its antigen

  • Visualize the exact binding interface at atomic resolution

  • Identify key interaction residues

• Hydrogen-deuterium exchange mass spectrometry:

  • Map regions of the target protein protected by YPS3 binding

  • Identify conformational epitopes not detectable by sequence analysis

  • Characterize binding dynamics